Understanding how RNA-binding proteins behave in cells
Elucidating the Mechanism in the Regulation of RNA-binding Protein Phase Separation
This study is looking at how certain proteins in our cells can clump together in a way that helps them work properly, and when they don’t, it can lead to brain diseases; the goal is to find ways to fix these clumps and help people with neurodegenerative conditions feel better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Thomas Jefferson University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10896224 on NIH RePORTER |
What this research studies
This research investigates how RNA-binding proteins (RBPs) can form liquid-like droplets within cells, which is crucial for the proper functioning of various cellular processes. When these proteins misbehave, they can lead to harmful aggregates associated with neurodegenerative diseases. The study aims to identify the mechanisms that regulate this phase separation and explore potential therapeutic strategies to reverse the harmful effects of protein aggregation. By focusing on nuclear import receptors, the research seeks to develop methods to restore normal cellular function and combat neurodegeneration.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with neurodegenerative disorders, such as Alzheimer's or ALS, where protein aggregation is a key issue.
Not a fit: Patients with non-neurodegenerative conditions or those without any protein aggregation-related issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for neurodegenerative diseases by reversing harmful protein aggregation.
How similar studies have performed: Previous research has shown promise in targeting protein phase separation as a therapeutic approach, indicating potential success for this novel investigation.
Where this research is happening
Philadelphia, United States
- Thomas Jefferson University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Guo, Lin — Thomas Jefferson University
- Study coordinator: Guo, Lin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.